Brain cancer survivor Mike Schuster celebrates a milestone he never thought possible.
brain cancer
FDA grants designations for OMRF brain tumor drug
The Oklahoma Medical Research Foundation is one step closer to beating rare forms of brain cancers.
OMRF brain tumor drug receives rare disease designations from the FDA
The drug treats fast-growing, deadly brain cancers with no effective treatment.
New use for OMRF brain cancer treatment could extend lives
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF discovers compound that could fight deadly cancer
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.